文献速递免疫规划营养与食品安全

载重组SEB蛋白可溶微针经皮免疫可抵御致死性肠毒素攻击

Transcutaneous immunization of recombinant Staphylococcal enterotoxin B protein using a dissolving microneedle provides potent protection against lethal enterotoxin challenge.
PubMed 文献 · Vaccine · 2019-05-27

研究制备载重组金黄色葡萄球菌肠毒素B(rSEB)蛋白的可溶微针,评估其体外特性与小鼠经皮免疫效果。结果显示微针5分钟内穿透小鼠皮肤、穿透深度260 µm并延长抗原体内滞留;全剂量微针组小鼠产生高水平SEB特异性抗体并获100%保护,半剂量组保护率为60%。

要点

  • 载rSEB可溶微针5分钟内穿透小鼠皮肤,穿透深度260 µm。
  • 全剂量微针组小鼠获100%保护,半剂量组保护率为60%。
  • 微针制备前后rSEB蛋白粒径不变,仅引起短暂轻微红斑。

核心结论

  • 载rSEB蛋白可溶微针有望成为治疗SEB中毒的经皮免疫策略。

研究设计与样本

  • 制备以2%硫酸软骨素和0.8%海藻糖为材料的载rSEB蛋白可溶微针,并在小鼠中评估其特性、免疫原性与保护效力。

主要发现

  • 载rSEB可溶微针5分钟内穿透小鼠皮肤,穿透深度260 µm,并显著延长抗原体内滞留时间。
  • 微针制备前后rSEB蛋白粒径不变。
  • 给药初期引起轻微红斑,数小时内消退。
  • 全剂量微针组小鼠产生高水平SEB特异性抗体,对致死性SEB毒素攻击提供100%保护。
  • 半剂量微针组小鼠保护率为60%。

临床怎么用

  • 可溶微针经皮免疫可作为SEB中毒候选预防策略,但半剂量保护率降至60%,提示需保证全程剂量。

局限性

  • 研究仅在小鼠中进行,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Staphylococcal enterotoxin B (SEB) produced by the Staphylococcus aureus bacteriumis most commonly associated with food poisoning and is known to also cause toxic shock syndrome. Currently, no approved vaccine or specific drug is available to treat SEB intoxication. In this study, we fabricated dissolving microneedles (MNs) loaded with recombinant SEB (rSEB) protein, and evaluated its characteristics, including dissolution profile, protein particle size, insertion depth, antigen retention time in vivo, and skin irritation. Our results showed that rSEB protein-loaded dissolving MNs made of chondroitin sulfate (2%) and trehalose (0.8%) could easily penetrate into the mouse skin within 5 min. The rSEB particle size was unchanged before and after MN fabrication. The skin penetration depth of the MNs was 260 µm. Moreover, the MNs also significantly extended the antigen retention time in vivo. rSEB protein-loaded dissolving MNs also triggered slight erythema at the beginning of administration, but this erythema disappeared within a few hours. More importantly, we investigated the immunogenicity and protective efficacy of rSEB protein-loaded dissolving MNs. Challenge studies in mice revealed that mice in full-dose MN group had a high level of SEB specific antibody response thatprovided100% protection against a lethal SEB toxin challenge. However, there was only 60% protection observed in mice that were in the half-dose MN (dose sparing) group. We also determined the pathological alterations in the tissues of the immunized mice. Taken together, these dissolving MNs may present a promising transcutaneous immunization strategy for treating SEB intoxication.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu S, Zhang S, Duan Y, et al. Transcutaneous immunization of recombinant Staphylococcal enterotoxin B protein using a dissolving microneedle provides potent protection against lethal enterotoxin challenge. Vaccine. 2019. PMID: 31147275. doi:10.1016/j.vaccine.2019.05.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。